The long-awaited advice on the designation of antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans has been released by EMA and the European Commission.

FVE particularly applauds the science-based assessment that fully implements the One Health approach. This advice confirms that the EU remains strongly anchored to an evidence-based and holistic approach to ensure the health and welfare of humans and animals in Europe

The advice safeguards the availability of all important substances for veterinary medicine, including 3rd and 4th generation cephalosporins, polymyxins and colistin, macrolides and fluoroquinolones.